An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies
- PMID: 3793386
An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies
Abstract
The present study was aimed at defining the standard conditions for predictive chemosensitivity testing of human leukaemias. The in vitro cytotoxic potential of 11 anticancer drugs against L1210 murine leukaemia was comparatively determined 3 and 48 h after in vitro exposure of leukaemia cells to these agents. In preliminary testing, drug-induced damage was estimated in terms of percent inhibition of: tumour cell proliferation, by microscopic determination of viable cell numbers; and DNA synthesis, by measuring the extent of incorporation of the labelled nucleoside 125IUdR. Since the two tests appeared to yield comparable results, all subsequent experiments on the various murine tumours were performed using the radiolabel incorporation technique. The results obtained pointed out that this metabolic assay performed 48 hours after drug exposure appears to be capable of predicting both "spontaneous" and "induced" in vivo resistance of murine leukaemias.
Similar articles
-
[A short term test suitable for in vitro prediction of the drug sensitivity of human leukemias: a preliminary study on murine experimental neoplasms].Boll Soc Ital Biol Sper. 1984 Feb 28;60(2):413-9. Boll Soc Ital Biol Sper. 1984. PMID: 6712803 Italian.
-
[In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].Boll Soc Ital Biol Sper. 1984 Jul 31;60(7):1369-75. Boll Soc Ital Biol Sper. 1984. PMID: 6477749 Italian.
-
Antitumor activity of novel ailanthone derivatives in vitro and in vivo.Anticancer Res. 1988 Jul-Aug;8(4):573-9. Anticancer Res. 1988. PMID: 3178149
-
A modified screening system to select new cytostatic drugs.Behring Inst Mitt. 1984 May;(74):301-28. Behring Inst Mitt. 1984. PMID: 6383326 Review. No abstract available.
-
Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.Adv Pharmacol Chemother. 1984;20:1-20. doi: 10.1016/s1054-3589(08)60263-x. Adv Pharmacol Chemother. 1984. PMID: 6398966 Review. No abstract available.
Cited by
-
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.Cancer Chemother Pharmacol. 1990;26(5):345-51. doi: 10.1007/BF02897291. Cancer Chemother Pharmacol. 1990. PMID: 2208576